Naloxone Hydrochloride Spray
Product Images NDC 42291-493

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Naloxone Hydrochloride (NDC 42291-493). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Xx (493 01)

Xx (493 01)
This is a description of Naloxone Hydrochloride Nasal Spray, which contains 4 mg and is used for the emergency treatment of opioid overdose. The spray is specifically designed for nasal use and should not be tested before use. Each nasal spray device contains one dose of medicine and sprays just one time. It should be stored at room temperature or refrigerated between 2°C to 25°C (36°F to 77°F) and should not be frozen. Excessive heat above 40°C (104°F) should be avoided.*
FDA Label Image

X (493 02)

FDA Label Image

1 Check (Naloxone Hydrochloride Nasal Spray 1)

FDA Label Image

Step 4 (Naloxone Hydrochloride Nasal Spray 10)

FDA Label Image

5 Stay (Naloxone Hydrochloride Nasal Spray 11)

FDA Label Image

2 Give (Naloxone Hydrochloride Nasal Spray 2)

FDA Label Image

3 Call (Naloxone Hydrochloride Nasal Spray 3)

FDA Label Image

Step 4 (Naloxone Hydrochloride Nasal Spray 4)

FDA Label Image

5 Stay (Naloxone Hydrochloride Nasal Spray 5)

FDA Label Image

Hand (Naloxone Hydrochloride Nasal Spray 6)

FDA Label Image

1 Check (Naloxone Hydrochloride Nasal Spray 7)

FDA Label Image

2 Give (Naloxone Hydrochloride Nasal Spray 8)

FDA Label Image

3 Call (Naloxone Hydrochloride Nasal Spray 9)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.